A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance.
Background: Melasma is the commonest cause of facial hypermelanosis in skin type IV-VI. First-line treatment includes a triple combination containing topical corticosteroid and hydroquinone which have side effects on prolonged use. Chemical peels are a second-line management option with the laser be...
| Publicado en: | Indian Journal of Dermatology, Venereology & Leprology Vol. 87; no. 1; pp. 51 - 59 |
|---|---|
| Autores principales: | , , |
| Formato: | research randomized controlled trial Journal Article |
| Publicado: |
Scientific Scholar LLC
Jan/Feb2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |